Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PRAD | rs756352 | chr1:31799868 | A/C | 8.25E-6 | 494 | 22.87 | 31.28 | 30.93 | KM Plot |
| PRAD | rs75656642 | chr1:202694109 | A/C | 9.91E-6 | 493 | 30.93 | 29.5 | 27.92 | KM Plot |
| PRAD | rs75657991 | chr5:154181996 | T/G | 1.03E-8 | 490 | 30.27 | 32.85 | 20.47 | KM Plot |
| PRAD | rs7567313 | chr2:107441568 | G/C | 3.23E-5 | 492 | 30.93 | 30.27 | 32.63 | KM Plot |
| PRAD | rs75677081 | chr5:154183542 | C/T | 0 | 493 | 30.2 | 35.57 | 4.87 | KM Plot |
| PRAD | rs75685042 | chr12:9469965 | G/A | 0 | 486 | 31.28 | 24.93 | 4.87 | KM Plot |
| PRAD | rs7568705 | chr2:239081808 | C/T | 1.86E-5 | 479 | 32.3 | 28.27 | 28.67 | KM Plot |
| PRAD | rs75717040 | chr1:93795344 | G/A | 3.62E-6 | 494 | 31.3 | 28.13 | 18.97 | KM Plot |
| PRAD | rs7577816 | chr2:47156455 | G/C | 6.41E-6 | 492 | 30.8 | 32.4 | 36.85 | KM Plot |
| PRAD | rs75782786 | chr6:43320055 | C/A | 5.07E-10 | 485 | 31.27 | 28.57 | 44.3 | KM Plot |
| PRAD | rs75793404 | chr9:72843172 | C/T | 1.73E-5 | 493 | 30.8 | 31.35 | 22.45 | KM Plot |
| PRAD | rs7579662 | chr2:161915810 | G/A | 3.88E-5 | 493 | 29.43 | 32.13 | 29.68 | KM Plot |
| PRAD | rs75812775 | chr12:728564 | C/T | 0.000148 | 490 | 31.33 | 28.13 | 22.67 | KM Plot |
| PRAD | rs75831238 | chr5:154224763 | C/T | 8.84E-9 | 493 | 30.2 | 33.07 | 20.47 | KM Plot |
| PRAD | rs75852281 | chr11:129984141 | G/A | 2.25E-6 | 489 | 30.93 | 30.47 | 22.8 | KM Plot |